Health
CRISPR gene editing has made it possible to cure sickle cell disease, which affects millions worldwide, but most people with the condition won't be able to afford the cost of the treatment
8 March 2023
Millions of people could now be cured of sickle cell disease, a serious inherited blood condition, thanks to CRISPR gene editing – but the cost of treatment is so high that few people are likely to receive it in the foreseeable future.
“We have been able to cure sickle cell disease using gene editing,” Julie Makani at the Muhimbili University of Health in Tanzania told the International Summit on Human Genome Editing in London on 6 …
View introductory offers
No commitment, cancel anytime*
Offer ends 14th April 2023.
*Cancel anytime within 14 days of payment to receive a refund on unserved issues.
Inclusive of applicable taxes (VAT)
or
Existing subscribers
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles